stella
beta
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy — Stella
Recruiting
Back to Prostate Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
MedStar Washington Hospital Center, Washington D.C., District of Columbia
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington D.C., District of Columbia
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey
View full record on ClinicalTrials.gov